AF
XERS icon

Allworth Financial’s Xeris Biopharma Holdings XERS Stock Holding History

Allworth Financial’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,315
Closed -$13.4K – 5425
2026
Q1 		$13.4K Buy
+2,315
New +$15.3K ﹤0.01% 3288
2025
Q4 		– Sell
-1,765
Closed -$14.4K – 5308
2025
Q3 		$14.4K Sell
1,765
-311
-15% -$2.07K ﹤0.01% 2910
2025
Q2 		$9.7K Buy
2,076
+180
+9% +$825 ﹤0.01% 2901
2025
Q1 		$8.12K Hold
1,896
– – ﹤0.01% 2520
2024
Q4 		$6.24K Hold
1,896
– – ﹤0.01% 2654
2024
Q3 		$5.4K Hold
1,896
– – ﹤0.01% 2534
2024
Q2 		$4.49K Sell
1,896
-190
-9% -$383 ﹤0.01% 2569
2024
Q1 		$4.61K Buy
2,086
+190
+10% +$492 ﹤0.01% 2443
2023
Q4 		$4.46K Hold
1,896
– – ﹤0.01% 2322
2023
Q3 		$3.53K Hold
1,896
– – ﹤0.01% 2285
2023
Q2 		$4.97K Hold
1,896
– – ﹤0.01% 2099
2023
Q1 		$3.09K Buy
1,896
+196
+12% +$245 ﹤0.01% 2222
2022
Q4 		$2.26K Buy
1,700
+1,200
+240% +$1.69K ﹤0.01% 2198
2022
Q3 		$1K Hold
500
– – ﹤0.01% 2549
2022
Q2 		$1K Hold
500
– – ﹤0.01% 2295
2022
Q1 		$1K Hold
500
– – ﹤0.01% 2038
2021
Q4 		$1K Hold
500
– – ﹤0.01% 1873
2021
Q3 		$1K Hold
500
– – ﹤0.01% 1812
2021
Q2 		$2K Sell
500
-1,876
-79% -$7.16K ﹤0.01% 1417
2021
Q1 		$11K Buy
2,376
+1,076
+83% +$5.8K ﹤0.01% 971
2020
Q4 		$6K Sell
1,300
-100
-7% -$500 ﹤0.01% 964
2020
Q3 		$8K Buy
+1,400
New +$5.6K ﹤0.01% 770

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allworth Financial's XERS Position: Q2 2026 in Review

Allworth Financial sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 2,315 shares — an estimated $13.4K sold.

Allworth Financial first reported a position in XERS in Q3 2020 and held it in 22 quarters. The position peaked at $14.4K in Q3 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Allworth Financial reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
  • Allworth Financial sold 2,315 Xeris Biopharma Holdings shares in Q2 2026, an estimated $13.4K.
  • Allworth Financial first reported a position in Xeris Biopharma Holdings in Q3 2020 and held it in 22 quarters.
  • Allworth Financial's Xeris Biopharma Holdings position peaked at $14.4K in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.